IntelliPharmaCeutics Announces First Quarter 2012 Results  
4/13/2012 9:54:55 AM

TORONTO, April 12, 2012 (GLOBE NEWSWIRE) -- Intellipharmaceutics International Inc. (Nasdaq:IPCI) (TSX:I), a pharmaceutical company specializing in the research, development and manufacture of novel and generic controlled-release and targeted-release oral solid dosage drugs, today reported the results of operations for the three months ended February 29, 2012. All dollar amounts referenced herein are in United States dollars unless otherwise noted.